Unknown PHASE4 INTERVENTIONAL 2-arm NCT04657952

Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients

Sphenopalatine Ganglion Block With Adrenaline Additive for Post-Dural Puncture Headache in Orthopedic Patients: A Randomized Controlled Study

Sponsor: Tanta University

Conditions Adrenaline Orthopedic Post-Dural Puncture Headache Randomized Controlled Study Sphenopalatine Ganglion Block

Interventions Medical Treatment Sphenopalatine Ganglion Block

Updated 4 times since 2021 Last updated: Dec 6, 2020 Started: Dec 10, 2020 Primary completion: May 10, 2021 Completion: May 20, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04657952, this PHASE4 trial focuses on Adrenaline and Orthopedic and remains ongoing. Sponsored by Tanta University, it has been updated 4 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jan 2023 [monthly]

Not Yet Recruiting PHASE4

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tanta University

Data source: Tanta University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.